Project Details
Description
A Phase I, Multi-Center, Open-Label, Drug-Drug Interaction Study to Assess the Effect of TKI258 on the Pharmacokinetics of Caffeine, Diclofenac, Omeprazole and Midazolam Administered
| Status | Finished |
|---|---|
| Effective start/end date | 9/28/11 → 8/31/13 |
Funding
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.